Inhibition of Amino Acid Metabolism Selectively Targets Human Leukemia Stem Cells

Jones, Courtney L., Stevens, Brett M., D'Alessandro, Angelo, Reisz, Julie A., Culp-Hill, Rachel, Nemkov, Travis, Pei, Shanshan, Khan, Nabilah +8 more·2018·Cancer Cell

DOI 10.1016/j.ccell.2018.10.005

Cited by (591)

Items 201–300 of 591

Lipid metabolism in cancer stem cells: reprogramming, mechanisms, crosstalk, and therapeutic approaches
Haksoo Lee, Sujin Park, Jong Won Lee, Chaeyoung Lee, Hyunkoo Kang, JiHoon Kang, Jung Sub Lee, Eunguk Shin, HyeSook Youn, BuHyun Youn · 2025 · Cellular Oncology
Druggable Biochemical Pathways and Potential Therapeutic Alternatives to Target Leukemic Stem Cells and Eliminate the Residual Disease in Chronic Myeloid Leukemia
Fabien Muselli, Jean‐François Peyron, Didier Mary · 2019 · International Journal of Molecular Sciences
When cancer drug resistance meets metabolomics (bulk, single-cell and/or spatial): Progress, potential, and perspective
Zhiqiang Zhang, Chaohui Bao, Lu Jiang, Shan Wang, Kankan Wang, Chang Lu, Hai Fang · 2023 · Frontiers in Oncology
Tumor Metabolism as a Regulator of Tumor–Host Interactions in the B-Cell Lymphoma Microenvironment—Fueling Progression and Novel Brakes for Therapy
Anna C. Beielstein, Christian Philipp Pallasch · 2019 · International Journal of Molecular Sciences
Subtype discrimination of acute myeloid leukemia based on plasma SERS technique
Minlu Ye, Yang Chen, Yuting Wang, Lijing Xiao, Qiu Lin, Hongyue Lin, Zhengwei Duan, Shangyuan Feng, Yingping Cao, Jingxi Zhang et al. · 2022 · Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy
Iron metabolism: backfire of cancer cell stemness and therapeutic modalities
Rong Yu, Yinhui Hang, Hsiang‐i Tsai, Dongqing Wang, Haitao Zhu · 2024 · Cancer Cell International
CX43-mediated mitochondrial transfer maintains stemness of KG-1a leukemia stem cells through metabolic remodeling
Hui‐Hui Fu, Xiaoqing Xie, Liuyue Zhai, Yi Liu, Yifeng Tang, Sanxiu He, Jun Li, Qing Xiao, Guofa Xu, Zailin Yang et al. · 2024 · Stem Cell Research & Therapy
Unraveling the underlying mechanisms of cancer stem cells in therapeutic resistance for optimizing treatment strategies
Yunhan Tan, Siyuan Qin, Zhe Zhang, Y. Liu, Li Zhou, Bowen Li, Edouard Collins Nice, Yuanyuan Zhang, Jing Jing · 2025 · MedComm – Oncology
m6A/IGF2BP3-driven serine biosynthesis fuels AML stemness and metabolic vulnerability
Feng Huang, Yushuai Wang, Xiuxin Zhang, Weiwei Gao, Jingwen Li, Ying Yang, Hongjie Mo, Emily A. Prince, Yifei Long, Jiacheng Hu et al. · 2025 · Nature Communications
Targeting cancer stem cells with antibiotics inducing mitochondrial dysfunction as an alternative anticancer therapy
Igor Karp, Alex Lyakhovich · 2022 · Biochemical Pharmacology
Ascorbate Plus Buformin in AML: A Metabolic Targeted Treatment
Cristina Banella, Gianfranco Catalano, Serena Travaglini, Elvira Pelosi, Tiziana Ottone, Alessandra Zaza, Gisella Guerrera, Daniela Francesca Angelini, Pasquale Niscola, Mariadomenica Divona et al. · 2022 · Cancers
A primary hierarchically organized patient-derived model enables in depth interrogation of stemness driven by the coding and non-coding genome
Héléna Boutzen, Seyed Ali Madani Tonekaboni, Michelle Chan‐Seng‐Yue, Alex Murison, Naoya Takayama, Nathan Mbong, Elvin Wagenblast, Elias Orouji, Andrea Arruda, Amanda Mitchell et al. · 2022 · Leukemia
Metabolic Escape Routes of Cancer Stem Cells and Therapeutic Opportunities
Alice Turdo, Gaetana Porcelli, Caterina D’Accardo, Simone Di Franco, Francesco Verona, Stefano Forte, Dario Giuffrida, Lorenzo Memeo, Matilde Todaro, Giorgio Stassi · 2020 · Cancers
Lactate dehydrogenase A-coupled NAD+ regeneration is critical for acute myeloid leukemia cell survival
Ayşegül Erdem, Séléna Kaye, Francesco Caligiore, Manuel Johanns, Fleur Leguay, Jan Jacob Schuringa, Keisuke Ito, Guido T. Bommer, Nick van Gastel · 2025 · Cancer & Metabolism
CD123 as a Therapeutic Target Against Malignant Stem Cells
Mayumi Sugita, Mónica L. Guzmán · 2020 · Hematology/Oncology Clinics of North America
Insights on Metabolic Reprogramming and Its Therapeutic Potential in Acute Leukemia
Ludovica Di Martino, Valeria Tosello, Edoardo Peroni, Erich Piovan · 2021 · International Journal of Molecular Sciences
Emerging drugs targeting cellular redox homeostasis to eliminate acute myeloid leukemia stem cells
Rafaela G.A. Costa, Suellen L. R. Silva, Ingrid R. S. B. Dias, Maiara de S. Oliveira, Ana Carolina Rodrigues, Rosane B. Dias, Daniel Pereira Bezerra · 2023 · Redox Biology
Co-Targeting of HDAC, PI3K, and Bcl-2 Results in Metabolic and Transcriptional Reprogramming and Decreased Mitochondrial Function in Acute Myeloid Leukemia
Katie Hege-Hurrish, Xinan Qiao, Xinyu Li, Yongwei Su, Jenna L. Carter, Jun Ma, Hasini A. Kalpage, Maik Hüttemann, Holly J. Edwards, Guan Wang et al. · 2022 · SSRN Electronic Journal
Insights into Metabolic Reprogramming in Tumor Evolution and Therapy
Ching‐Feng Chiu, Jonathan Jaime G. Guerrero, Ric Ryan H. Regalado, Jiayan Zhou, Kin Israel Notarte, Yuwei Lu, Paolo C. Encarnacion, Cidne Carles, Edrian M. Octavo, Dan Christopher I. Limbaroc et al. · 2024 · Cancers
Metabolism in Cancer Stem Cells: Targets for Clinical Treatment
Gui-Min Wen, Xu Xiaoyan, Xia Pu · 2022 · Cells
Therapy-Resistant Acute Myeloid Leukemia Stem Cells Are Resensitized to Venetoclax + Azacitidine by Targeting Fatty Acid Desaturases 1 and 2
Rachel Culp‐Hill, Brett M. Stevens, Courtney L. Jones, Shanshan Pei, Monika Dzieciątkowska, Mohammad Minhajuddin, Craig T. Jordan, Angelo D’Alessandro · 2023 · Metabolites
Metabolomic profile of acute myeloid leukaemia parallels of prognosis and response to therapy
Łukasz Bołkuń, Tomasz Pienkowski, Julia Siemińska, Joanna Godzień, Karolina Pietrowska, Janusz S. Kloczko, Agnieszka Wierzbowska, Marcin Moniuszko, Mariusz Z. Ratajczak, Adam Jacek Kretowski et al. · 2023 · Scientific Reports
Crosstalk between autophagy and metabolism: implications for cell survival in acute myeloid leukemia
Yongfeng Chen, Jia Chen, Zhenyou Zou, Linglong Xu, Jing Li · 2024 · Cell Death Discovery
Identification and Characterization of Multiple Myeloma Stem Cell-Like Cells
Wancheng Guo, Haiqin Wang, Peng Chen, Xiaokai Shen, Boxin Zhang, Jing Liu, Hongling Peng, Xiaojuan Xiao · 2021 · Cancers
Autophagy and Metabolism in Normal and Malignant Hematopoiesis
Ioanna Ε. Stergiou, Efstathia K. Kapsogeorgou · 2021 · International Journal of Molecular Sciences
Targeting the metabolism of cancer stem cells by energy disruptor molecules
Tahere Dadgar, Nasim Ebrahimi, Amir Reza Gholipour, Maryam Akbari, Leila Khani, Amirhossein Ahmadi, Michael Richard Hamblin · 2021 · Critical Reviews in Oncology/Hematology
TKTL1 Knockdown Impairs Hypoxia-Induced Glucose-6-phosphate Dehydrogenase and Glyceraldehyde-3-phosphate Dehydrogenase Overexpression
Inês Baptista, Effrosyni Karakitsou, Jean‐Baptiste Cazier, Ulrich L. Günther, Silvia Marín, Marta Cascante · 2022 · International Journal of Molecular Sciences
Germline mutations in mitochondrial complex I reveal genetic and targetable vulnerability in IDH1-mutant acute myeloid leukaemia
Mahmoud Adel Bassal, Saumya E. Samaraweera, Kelly SY Lim, Brooks A. Benard, Sheree Bailey, Satinder Kaur, Paul Leo, John Toubia, Chloe A. L. Thompson-Peach, Tran Nguyen et al. · 2022 · Nature Communications
Mitochondria in oral cancer stem cells: Unraveling the potential drug targets for new and old drugs
Ivonne Olmedo, Daniela Martínez, Javiera Carrasco-Rojas, José Antonio Jara · 2023 · Life Sciences
Mitochondrial Homeostasis in AML and Gasping for Response in Resistance to BCL2 Blockade
Michael Robert Savona, Jeffrey C. Rathmell · 2019 · Cancer Discovery
Targeting acute myeloid leukemia stem cells: Current therapies in development and potential strategies with new dimensions
Yuxin Tan, Qiuji Wu, Fuling Zhou · 2020 · Critical Reviews in Oncology/Hematology
Metabolic Plasticity of Cancer Stem Cells in Response to Microenvironmental Cues
Yunong Xie, Stephanie Ma, Man Tong · 2022 · Cancers
Targeting the BCL2 Family: Advances and Challenges in BH3 Mimetic-Based Therapies
Nabanita Mukherjee, James Sheetz, Yiqun G. Shellman · 2025 · International Journal of Molecular Sciences
Metabolic Constrains Rule Metastasis Progression
Niccolò Roda, Valentina Gambino, Marco Giorgio · 2020 · Cells
Glutamine Metabolism Mediates Sensitivity to Respiratory Complex II Inhibition in Acute Myeloid Leukemia
Alessia Roma, Matthew Tcheng, Nawaz Ahmed, Sarah Walker, Preethi Jayanth, Mark David Minden, Kristin J. Hope, Praveen P. N. Rao, Jessica Luc, Andrew C. Doxey et al. · 2022 · Molecular Cancer Research
Monocytic Differentiation in Acute Myeloid Leukemia Cells: Diagnostic Criteria, Biological Heterogeneity, Mitochondrial Metabolism, Resistance to and Induction by Targeted Therapies
Øystein Bruserud, Frode Selheim, Maria Hernandez-Valladares, Håkon Reikvam · 2024 · International Journal of Molecular Sciences
Can we selectively target AML stem cells?
Craig T. Jordan · 2019 · Best Practice & Research Clinical Haematology
Characteristics of Oxidative Phosphorylation-Related Subtypes and Construction of a Prognostic Signature in Ovarian Cancer
Jiaojiao Lu, Shuai Zhen, Xu Li · 2024 · Current Gene Therapy
High mtDNA content identifies oxidative phosphorylation-driven acute myeloid leukemias and represents a therapeutic vulnerability
Diego A. Pereira‐Martins, Isabel Weinhäuser, Emmanuel Griessinger, Juan Luiz Coelho‐Silva, Douglas RA Silveira, Dominique Sternadt, Ayşegül Erdem, Bruno Kosa Lino Duarte, Prodromos Chatzikyriakou, Lynn Swun Quek et al. · 2025 · Signal Transduction and Targeted Therapy
Myelodysplastic Syndromes and Metabolism
Ekaterina Balaian, Manja Wobus, Martin Bornhäuser, Triantafyllos Chavakis, Katja Sockel · 2021 · International Journal of Molecular Sciences
GPRC5C drives branched-chain amino acid metabolism in leukemogenesis
Yu Wei Zhang, Talía Velasco-Hernández, Julian Mess, Maria‐Eleni Lalioti, Mari Carmen Romero-Mulero, Nadine Obier, Nikolaos Karantzelis, Jasmin Rettkowski, Katharina Schönberger, Noémie Karabacz et al. · 2023 · Blood Advances
Bidirectional interplay between metabolism and epigenetics in hematopoietic stem cells and leukemia
Yu Wei Zhang, Katharina Schönberger, Nina Cabezas‐Wallscheid · 2023 · The EMBO Journal
Spermidine metabolism regulates leukemia stem and progenitor cell function through KAT7 expression in patient-derived mouse models
Vincent Rondeau, Jacob M. Berman, Tianyi Ling, Cristiana O’Brien, Rachel Culp‐Hill, Julie A. Reisz, Mark Wunderlich, Yun Chueh, Karina E. Jiménez-Camacho, Christina Sexton et al. · 2024 · Science Translational Medicine
Unraveling Venetoclax Resistance: Navigating the Future of HMA/Venetoclax-Refractory AML in the Molecular Era
Theodora Chatzilygeroudi, Theodoros Karantanos, Vasiliki Pappa · 2025 · Cancers
ALWAYS STRESSED BUT NEVER EXHAUSTED: HOW STEM CELLS IN MYELOID NEOPLASMS AVOID EXTINCTION IN INFLAMMATORY CONDITIONS
Helong Zhao, Michael W. Deininger · 2023 · Blood
Alteration of gut microbiome and correlated amino acid metabolism are associated with acute myelocytic leukemia carcinogenesis
Jing Xu, Yong Kang, Yan Zhong, Wencan Ye, Tianle Sheng, Qingming Wang, Jifu Zheng, Qiuyue Yang, Ping Yi, Zhenjiang Li · 2023 · Cancer Medicine
Therapeutic targeting of leukemia stem cells in acute myeloid leukemia
Karina Barbosa, A. Deshpande · 2023 · Frontiers in Oncology
Arsenic trioxide synergistically promotes the antileukaemic activity of venetoclax by downregulating Mcl-1 in acute myeloid leukaemia cells
Hyunsoo Cho, Ji Eun Jang, Ju-In Eom, Hoi-Kyung Jeung, Haerim Chung, Jin Seok Kim, June‐Won Cheong, Yoo Hong Min · 2021 · Experimental Hematology and Oncology
Targeted therapy in acute myeloid leukemia: Resistance and overcoming strategy
Feifeng Song, Sisi Lin, Tong Xu, Chang Yang, Bold Sharavyn, Hua Naranmandura, Yiwen Zhang, Ping Cheong Huang · 2025 · Drug Resistance Updates
Prediction of prognosis and immunotherapy response of amino acid metabolism genes in acute myeloid leukemia
Hui Zhou, Fengjuan Wang, Ting Niu · 2022 · Frontiers in Nutrition
Acquired resistance to venetoclax plus azacitidine in acute myeloid leukemia: In vitro models and mechanisms
Jenna L. Carter, Yongwei Su, Xinan Qiao, Jianlei Zhao, Guan Wang, Mackenzie Howard, Holly J. Edwards, Xun Bao, Jing Li, Maik Hüttemann et al. · 2023 · Biochemical Pharmacology
PDP1 is a key metabolic gatekeeper and modulator of drug resistance in FLT3-ITD-positive acute myeloid leukemia
Islam Alshamleh, Nina Kurrle, Philipp Makowka, Raj Bhayadia, Rahul Kumar, Sebastian Süsser, Marcel Seibert, Damian L. Ludig, Sebastian Wolf, Sebastian E. Koschade et al. · 2023 · Leukemia
IL-21/IL-21R signaling renders acute myeloid leukemia stem cells more susceptible to cytarabine treatment and CAR T cell therapy
Viviana Rubino, Michelle Hüppi, Sabine Höpner, Luigi Tortola, Noah Schnüriger, Hugo Legenne, Lea Taylor, Svenja Voggensperger, Irene Keller, Rémy Bruggmann et al. · 2024 · Cell Reports Medicine
Six1 is negatively correlated with poor prognosis and reduces 5-fluorouracil sensitivity via attenuating the stemness of hepatocellular carcinoma cells
Kehe Chen, Haiming Wei, Jinfei Pan, Zhenxiang Chen, Deng Pan, Ting Gao, Jingning Huang, Min Huang, Mei Ou, Wenhe Zhong · 2019 · European Journal of Pharmacology
Irradiation Causes Alterations of Polyamine, Purine, and Sulfur Metabolism in Red Blood Cells and Multiple Organs
Micaela Kalani Roy, Francesca La Carpia, Francesca Isabelle Cendali, Sebastian Fernando, Chiara Moriconi, Bogusław S. Wójczyk, Lin Wang, Travis G. Nemkov, Eldad A. Hod, Angelo D’Alessandro · 2022 · Journal of Proteome Research
Acute Myeloid Leukaemia Drives Metabolic Changes in the Bone Marrow Niche
Maynard, Rebecca S., Hellmich, Charlotte, Bowles, Kristian M., Rushworth, Stuart A. · 2022 · Frontiers in Oncology
Prognostic Implication of Plasma Metabolites in Gastric Cancer
Cao, Kang, Lyu, Yanping, Chen, Jingwen, He, Chenzhou, Lyu, Xuejie, Zhang, Yuling, Chen, Liangping, Jiang, Yu, Xiang, Jianjun, Liu, Baoying et al. · 2023 · International Journal of Molecular Sciences
IRE1α–XBP1 safeguards hematopoietic stem and progenitor cells by restricting pro-leukemogenic gene programs
Brendan M Barton, Francheska Son, Akanksha Verma, Saswat Kumar Bal, Qianzi Tang, Rui Wang, Katharine Umphred-Wilson, Rehan Khan, Josephine Trichka, Han Dong et al. · 2025 · Nature Immunology
Understanding and Targeting Metabolic Vulnerabilities in Acute Myeloid Leukemia: An Updated Comprehensive Review
Sridevi Addanki, Lana E. Kim, Alexandra McLean Stevens · 2025 · Cancers
Amino acid metabolism: challenges and opportunities for the therapeutic treatment of leukemia and lymphoma
Peiyun Liao, Ning Chang, Binyan Xu, Yingqi Qiu, Sheng Wang, Lijuan Zhou, Yanjie He, Xiaoling Xie, Yuhua Li · 2022 · Immunology and Cell Biology
α-Ketoglutarate dehydrogenase is a therapeutic vulnerability in acute myeloid leukemia
Scott E. Millman, Almudena Chaves Perez, Sudha Janaki‐Raman, Yu-Jui Ho, John P. Morris, Varun K. Narendra, Chi-Chao Chen, Benjamin T. Jackson, Jossie J. Yashinskie, Riccardo Mezzadra et al. · 2025 · Blood
Driving CAR T Stem Cell Targeting in Acute Myeloid Leukemia: The Roads to Success
Ilaria Marina Michelozzi, Efstratios Kirtsios, Alice Giustacchini · 2021 · Cancers
Unveiling novel insights in acute myeloid leukemia through single-cell RNA sequencing
Jianbiao Zhou, Wee Joo Chng · 2024 · Frontiers in Oncology
Dual-Targeted Therapy Circumvents Non-Genetic Drug Resistance to Targeted Therapy
Wei Wang, Yue Sun, Xiaobo Liu, Shaji Kunnathu Kumar, Fengyan Jin, Yun Dai · 2022 · Frontiers in Oncology
Higher-dose venetoclax with measurable residual disease-guided azacitidine discontinuation in newly diagnosed acute myeloid leukemia
Jonathan Aaron Gutman, Amanda C. Winters, Andrew Kent, Maria L. Amaya, Christine M. McMahon, Clayton A. Smith, Craig T. Jordan, Brett M. Stevens, Mohammad Minhajuddin, Shanshan Pei et al. · 2023 · Haematologica
Venetoclax combination therapy induces deep AML remission with eradication of leukemic stem cells and remodeling of clonal haematopoiesis
Romain Vazquez, Claire Bréal, Loria Zalmaï, Chloé Friedrich, Carole Almire, Adrien Contejean, Sylvain Barreau, Éric Grignano, Lise Willems, Bénédicte Deau et al. · 2021 · Blood Cancer Journal
Hypoxic, glycolytic metabolism is a vulnerability of B-acute lymphoblastic leukemia-initiating cells
Vivian Morris, Dahai Wang, Zhiheng Li, William Marion, Travis K. Hughes, Patricia Sousa, Taku Harada, Shannan Ho Sui, Sergey Naumenko, Jérémie Kalfon et al. · 2022 · Cell Reports
Acute myeloid leukemia: therapeutic targeting of stem cells
Cindy M. Pabon, H. Abbas, M. Konopleva · 2022 · Expert opinion on therapeutic targets
Systematic Construction and Validation of a Metabolic Risk Model for Prognostic Prediction in Acute Myelogenous Leukemia
Yun Wang, Fang Hu, Jinyuan Li, Run‐Cong Nie, Siliang Chen, Yanyu Cai, Lingling Shu, De-jun Deng, Jingbo Xu, Yang Liang · 2020 · Frontiers in Oncology
Functional Dependency Analysis Identifies Potential Druggable Targets in Acute Myeloid Leukemia
Yujia Zhou, Gregory Pal Takacs, Jatinder Kaur Lamba, Chris D. Vulpe, Christopher Ramin Cogle · 2020 · Cancers
Structure–activity relationship of avocadyne
Matthew Tcheng, Vitor L. S. Cunha, Nawaz Ahmed, Xiaofan Liu, Richard W. Smith, Kevin A. Rea, Tariq A. Akhtar, Angelo D’Alessandro, Mark David Minden, Jerry E. Vockley et al. · 2021 · Food & Function
In Vivo Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target
A. Vujović, Laura P. M. H. de Rooij, Ava Keyvani Chahi, H. Chen, Brian A. Yee, S. Loganathan, Lina Liu, Derek C H Chan, Amanda Tajik, Emily Tsao et al. · 2023 · Blood Cancer Discovery
Targeting human mitochondrial NAD(P)+-dependent malic enzyme (ME2) impairs energy metabolism and redox state and exhibits antileukemic activity in acute myeloid leukemia
Kun-Chi Chen, I.-Hsin Hsiao, Yu‐Nan Huang, Yu-Tung Chou, Yi‐Chun Lin, Ju‐Yi Hsieh, Yung‐Lung Chang, Kang‐Hsi Wu, Guang‐Yaw Liu, Hui‐Chih Hung · 2023 · Cellular Oncology
Mechanisms of Resistance to Small Molecules in Acute Myeloid Leukemia
Tonio Johannes Lukas Lang, Frédérik Damm, Lars Bullinger, Mareike Frick · 2023 · Cancers
Energy metabolism and drug response in myeloid leukaemic stem cells
Alfonso Enrique Bencomo-Alvarez, Andres J. Rubio, Mayra Alejandra Gonzalez, Anna M. Eiring · 2019 · British Journal of Haematology
The Constitutive Extracellular Protein Release by Acute Myeloid Leukemia Cells—A Proteomic Study of Patient Heterogeneity and Its Modulation by Mesenchymal Stromal Cells
Elise Aasebø, Annette K. Brenner, Even Birkeland, Tor Henrik Anderson Tvedt, Frode Selheim, Frode S. Berven, Øystein Bruserud · 2021 · Cancers
Amino Acid Metabolism-Related lncRNA Signature Predicts the Prognosis of Breast Cancer
Yinwei Dai, Zhi-kai Wen, Zhixuan Wu, Haodong Wu, Linxi Lv, Congzhi Yan, Conghui Liu, Zi-qiong Wang, Zheng Chen · 2022 · Frontiers in Genetics
Tumor Microenvironment Metabolism‐Modulating Nanomedicines for Enhancing Anti‐Tumor Immunity
Jiajie Chen, S. Fei, Zhihao Cao, Xinchun Liu, Weizhi Ji, Hangrong Chen, Yuyu Niu, Zebin Yang · 2025 · Small
Deciphering Metabolic Adaptability of Leukemic Stem Cells
Sweta B. Patel, Travis G. Nemkov, Angelo D’Alessandro, Robert S. Welner · 2022 · Frontiers in Oncology
Chasing leukemia differentiation through induction therapy, relapse and transplantation
Jennifer N. Saultz, Jeffrey W Tyner · 2022 · Blood Reviews
A novel fatty acid metabolism-related signature identifies features of the tumor microenvironment and predicts clinical outcome in acute myeloid leukemia
Haibin Zhang, Zhuo-Kai Sun, Fangmin Zhong, Fangyi Yao, Jing Liu, Jing Zhang, Nan Zhang, Lin Jin, Shuqi Li, Mei‐Yong Li et al. · 2022 · Lipids in Health and Disease
WNT4 Regulates Cellular Metabolism via Intracellular Activity at the Mitochondria in Breast and Gynecologic Cancers
Joseph L. Sottnik, Madeleine T. Shackleford, Sydney K. Robinson, Fabian R. Villagómez, Shaymaa Bahnassy, Steffi Oesterreich, Junxiao Hu, Zeynep Madak‐Erdogan, Rebecca Baab Riggins, Bradley R. Corr et al. · 2023 · Cancer Research Communications
Lactate Utilization Enables Metabolic Escape to Confer Resistance to BET Inhibition in Acute Myeloid Leukemia
Andrew J. Monteith, Haley Elizabeth Ramsey, Alexander James Silver, Donovan J. Brown, Dalton L. Greenwood, Brianna N. Smith, Ashley D. Wise, Juan Liu, Sarah D. Olmstead, Jackson Watke et al. · 2024 · Cancer Research
Integrative single‐cell expression and functional studies unravels a sensitization to cytarabine‐based chemotherapy through HIF pathway inhibition in AML leukemia stem cells
Talía Velasco-Hernández, Juan L. Trincado, Meritxell Vinyoles, Adrià Closa, Alba Martínez‐Moreno, Francisco Gutiérrez‐Agüera, Òscar Molina, Virginia Rodríguez-Cortez, Pau Ximeno-Parpal, Narcís Fernández‐Fuentes et al. · 2024 · HemaSphere
Ex vivo characterization of acute myeloid leukemia patients undergoing hypomethylating agents and venetoclax regimen reveals a venetoclax-specific effect on non-suppressive regulatory T cells and bona fide PD-1+TIM3+ exhausted CD8+ T cells
Giulia Corradi, Dorian Forte, Gianluca Cristiano, Andrea Polimeno, Marilena Ciciarello, Valentina Salvestrini, Lorenza Bandini, Valentina Robustelli, Emanuela Ottaviani, Michèle Cavo et al. · 2024 · Frontiers in Immunology
Acute Myeloid Leukaemia and Acute Lymphoblastic Leukaemia Classification and Metabolic Characteristics for Informing and Advancing Treatment
Carrie Wemyss, Emily J. Jones, Régis Stentz, Simon Richard Carding · 2024 · Cancers
Metabolic Vulnerabilities and Epigenetic Dysregulation in Myeloproliferative Neoplasms
Vasundhara Sharma, Kenneth L. Wright, Pearlie K. Epling‐Burnette, Gary W. Reuther · 2020 · Frontiers in Immunology
Predicting Prognosis in Acute Myeloid Leukemia Patients by Surface-Enhanced Raman Spectroscopy
Shuo Chen, Chunmeng Wang, Ruochen Zhu, Shanshan Zhu, Guojun Zhang · 2021 · Nanomedicine
Antimetabolic cooperativity with the clinically approved l-asparaginase and tyrosine kinase inhibitors to eradicate CML stem cells
Anne Trinh, Raeeka Khamari, Quentin Fovez, François‐Xavier Mahon, Béatrice Turcq, Didier Bouscary, Patrice Maboudou, Marie Joncquel-Chevalier Curt, Valérie Coiteux, Nicolas Germain et al. · 2021 · Molecular Metabolism
Mechanisms of resistance to targeted therapies for relapsed or refractory acute myeloid leukemia
Erin M. Kropp, Qing Li · 2022 · Experimental Hematology
Self-assembled nanomaterials for ferroptosis-based cancer theranostics
Guiqi Ma, Kaiqi Wang, Xinlong Pang, Shanbin Xu, Yuan Z. Gao, Yubo Liang, Jiaxin Yang, Xinyu Zhang, Xiao Jun Sun, Jian Dong · 2023 · Biomaterials Science
The mitochondrial transcription machinery genes are upregulated in acute myeloid leukemia and associated with poor clinical outcome
Sharon K. Wu, Nicole Fahmy, Houda Alachkar · 2019 · Metabolism Open
Targeting mitochondrial metabolism in acute myeloid leukemia
Madison Rex, Robert Williams, Kıvanç Birsoy, Martin S. Ta llman, Maximillian Stahl · 2021 · Leukemia & lymphoma/Leukemia and lymphoma
Put in a “Ca2+ll” to Acute Myeloid Leukemia
Clara Lewuillon, Marie-Océane Laguillaumie, Bruno Quesnel, Thierry Idziorek, Yasmine S. Touil, Loïc Lemonnier · 2022 · Cells
IPO11 regulates the nuclear import of BZW1/2 and is necessary for AML cells and stem cells
Boaz Nachmias, Dilshad H. Khan, Véronique Voisin, Arvind Singh Mer, Geethu Emily Thomas, Nadav Segev, Jonathan R. St‐Germain, Rose Hurren, Marcela Gronda, Aaron D. Botham et al. · 2022 · Leukemia
Glucose partitioning in the bone marrow micro-environment in acute myeloid leukaemia
Suqi Deng, Juan Du, Robert Peter Gale, Lu Wang, Huien Zhan, Fangshu Liu, Kexiu Huang, Hao Xu, Hui Zeng · 2023 · Leukemia
Extracellular Matrix Collagen I Differentially Regulates the Metabolic Plasticity of Pancreatic Ductal Adenocarcinoma Parenchymal Cell and Cancer Stem Cell
Diana Tavares‐Valente, Stefania Cannone, Maria Raffaella Greco, Tiago M. A. Carvalho, Fátima Baltazar, Odília Queirós, Gennaro Agrimi, Stephan J. Reshkin, Rosa Angela Cardone · 2023 · Cancers
Targeting metabolic vulnerabilities to overcome resistance to therapy in acute myeloid leukemia
Priyanka Sharma, Gautam M. Borthakur · 2023 · Cancer Drug Resistance
AML under the Scope: Current Strategies and Treatment Involving FLT3 Inhibitors and Venetoclax-Based Regimens
Szymon Milnerowicz, Julia Milnerowicz, Paulina Skowera, Magdalena Stelmach, Monika Lejman · 2023 · International Journal of Molecular Sciences
The m C methyltransferase NSUN2 promotes progression of acute myeloid leukemia by regulating serine metabolism
Songyu Li, Ya Liu, Xiang Wu, Minjia Pan, Hongxia Zhao, Yun‐Guang Hong, Qinghua Zhang, Shushu Hu, Ao-Rong Ouyang, Guangru Li et al. · 2025 · Cell Reports